Journal of Oral & Facial Pain and Headache is a leading peer-reviewed publication dedicated to advancing the understanding and treatment of orofacial pain and headache disorders. Published by QUINTESSENCE PUBLISHING CO INC in the United States, this journal serves as a critical resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and dentistry. With a commendable impact factor reflected in its 2023 rankings—Q1 in Dental (miscellaneous) and Q2 in both Anesthesiology & Pain Medicine and Clinical Neurology—this journal highlights cutting-edge research and innovative practices aimed at improving patient outcomes. The journal's content is accessible with an Open Access option, ensuring that significant findings reach a broad audience. Since its inception in 1993 and through its evolving scope, Journal of Oral & Facial Pain and Headache remains an indispensable platform for scholarly exchange and professional development in its specialized field.

Proteomics Clinical Applications, published by Wiley-VCH Verlag GmbH, is a pivotal journal in the realm of Clinical Biochemistry, with an impressive track record since its inception in 2007, continuing its impactful contributions to 2024. With an ISSN of 1862-8346 and an E-ISSN of 1862-8354, this prestigious journal currently holds a commendable Q2 ranking in Clinical Biochemistry, situated at the 54th percentile among its peers within Scopus rankings. Dedicated to the advancement of proteomics and its applications in clinical settings, Proteomics Clinical Applications serves as a bastion for innovative research, fostering knowledge exchange among scientists, healthcare professionals, and students alike. Through its focus on novel methodologies and translational research, the journal aims to bridge the gap between laboratory findings and clinical practice, significantly impacting patient care and outcomes. Although not open access, its content is accessible through various academic databases, ensuring that vital research reaches its intended audience.

Tremor and Other Hyperkinetic Movements is a pioneering open-access journal published by UBIQUITY PRESS LTD, dedicated to advancing the understanding of hyperkinetic movement disorders, including tremors. Since its inception in 2011, the journal has provided a vital platform for researchers, professionals, and students within the fields of neurology and movement disorders to share innovative findings, case studies, and clinical trials. With its contributions spanning from 2012 to 2024, the journal emphasizes high-quality research and fosters collaboration within the medical community. Although it holds a Scopus rank of 156 in the field of Medicine, particularly Cardiology and Cardiovascular Medicine, its value extends beyond metrics, inviting interdisciplinary dialogue about the mechanisms, treatments, and implications of these complex disorders. By offering unrestricted access to its content, Tremor and Other Hyperkinetic Movements ensures that crucial knowledge reaches a global audience, thus enabling advancements in clinical practices and improved patient outcomes.

Epilepsy & Behavior Reports, a distinguished journal published by ELSEVIER SCIENCE INC, specializes in the latest research and developments in the field of epilepsy and related behavioral conditions. Since its inception in 2019 as a fully Open Access journal, it has carved a niche for itself within the scientific community, providing an essential platform for researchers and clinicians focused on behavioral neuroscience and neurology. The journal's commitment to disseminating high-quality research is reflected in its current rankings within Scopus, placing it within the Q3 category for Behavioral Neuroscience and Clinical Neurology, underscoring its relevance to emerging trends in these fields. Located in the heart of New York, the journal strives to foster collaboration and innovation, making it a vital resource for academics, practitioners, and students eager to advance their understanding of epilepsy and its behavioral implications. The convergence of expertise and research in Epilepsy & Behavior Reports promises to illuminate crucial aspects of neurological health, driving forward the discourse that shapes future treatment and understanding of epilepsy.

Osteoarthritis and Cartilage, published by ELSEVIER SCI LTD, stands as a leading journal in the fields of Biomedical Engineering, Orthopedics and Sports Medicine, and Rheumatology. With an impressive impact factor reflective of its significant contribution to these domains, the journal has established a prominent place within the academic community since its inception in 1993. As evidenced by its Q1 quartile rankings across multiple categories, the journal is recognized for its high-quality peer-reviewed research that pushes the boundaries of knowledge regarding osteoarthritis and related cartilage disorders. Its rankings in Scopus, placing it among the top 2% of journals in Orthopedics and Sports Medicine and the top 7% in Rheumatology, further underscore its pivotal role in advancing clinical and biomechanical understandings of joint health. While open access options are not currently available, the journal encourages submissions that explore innovative solutions and therapeutic approaches to musculoskeletal conditions, fostering a collaborative environment among researchers, professionals, and students alike. Situated in the heart of London, it serves as a critical repository for cutting-edge research shaping the future of patient care and bone health.

Clinical Proteomics is a leading open-access journal, published by BMC since 2011, that aims to advance the field of proteomics by providing a platform for the dissemination of original research, critical reviews, and technological advancements in the analysis of proteins and their roles in health and disease. With an ISSN of 1542-6416 and E-ISSN 1559-0275, this esteemed journal covers a broad scope, converging years of research from 2004 to 2024. As a distinguished publication, it holds a Q1 ranking in Clinical Biochemistry and Q2 in both Molecular Biology and Molecular Medicine, reflecting its significance in the scientific community. Clinical Proteomics' commitment to open access ensures that its content is readily available to researchers, professionals, and students worldwide, facilitating the exchange of knowledge and fostering collaborative efforts in proteomic studies. Situated in the United Kingdom, this journal plays a pivotal role in shaping the future of biomedical research, appealing to anyone keen on the integration of proteomics in clinical practice and molecular investigation.

DYSPHAGIA, published by Springer, is a premier journal dedicated to advancing the study of swallowing disorders, a critical area within the fields of Gastroenterology, Otorhinolaryngology, and Speech and Hearing. With an ISSN of 0179-051X and E-ISSN 1432-0460, this journal serves as a vital resource for researchers, clinicians, and students alike, providing cutting-edge research and reviews that inform clinical practice and enhance patient care. As a testament to its influence, DYSPHAGIA holds a Q2 ranking in Gastroenterology and Q1 rankings in both Otorhinolaryngology and Speech and Hearing for 2023. Its Scopus rankings further position it among the leading journals in its field, highlighting its importance and impact within the academic community. The journal publishes contributions that encompass a spectrum of topics related to swallowing, making it an essential platform for disseminating knowledge and fostering innovative solutions in the management of dysphagia. Operating from New York, NY, DYSPHAGIA invites contributions that align with its mission to advance the understanding and treatment of swallowing disorders through rigorous scientific inquiry and discourse.

Discover Oncology, published by SPRINGER, is an influential journal based in Germany that focuses on the latest advancements in the fields of oncology and endocrinology. With an evolving scope that spans critical research from 2021 to 2024, this journal aims to provide a platform for innovative ideas and research findings that can significantly impact clinical practices. Although it currently holds a Q3 ranking in several Cancer Research and Endocrine category quartiles, its commitment to open access ensures that relevant knowledge is available to a wider audience, facilitating the exchange of ideas among researchers, professionals, and students. As evidenced by its growing presence in various medical spheres, including a Q2 ranking in Endocrinology and Diabetes, the journal plays a crucial role in advancing multidisciplinary research that integrates oncology with broader biological and medical parameters. For those in the field, Discover Oncology serves as both a resource and a community hub, encouraging collaboration and exploration of emerging findings that can lead to novel therapeutic approaches.

BMC Gastroenterology is a premier open-access journal published by BMC, dedicated to disseminating high-quality research in the field of gastroenterology. Established in 2001 and headquartered in the United Kingdom, this journal aims to enhance the understanding of gastrointestinal disorders through innovative research, reviews, and clinical studies. With an impressive impact factor and ranking within the Q2 category in gastroenterology and miscellaneous medicine for 2023, BMC Gastroenterology plays a critical role in advancing knowledge and practices in the field. The journal's commitment to open access ensures that researchers, professionals, and students worldwide can freely access and share vital findings and insights. Encouraging collaboration and knowledge transfer, BMC Gastroenterology is an essential resource for those dedicated to improving gastrointestinal health and outcomes.

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.